New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - beclometasone dipropionate 100ug (an overage of 15% is added) - powder filled inhalation capsule - 100 mcg - active: beclometasone dipropionate 100ug (an overage of 15% is added) excipient: gelatin   iron oxide black iron oxide red iron oxide yellow lactose monohydrate purified water   titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - beclometasone dipropionate 200ug (an overage 15% is added) - powder filled inhalation capsule - 200 mcg - active: beclometasone dipropionate 200ug (an overage 15% is added) excipient: gelatin   iron oxide black iron oxide red iron oxide yellow lactose monohydrate purified water   titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - beclometasone dipropionate 400ug (an overage of 15% is added) - powder filled inhalation capsule - 400 mcg - active: beclometasone dipropionate 400ug (an overage of 15% is added) excipient: gelatin   iron oxide black iron oxide red iron oxide yellow lactose monohydrate purified water   titanium dioxide

Ireland - English - HPRA (Health Products Regulatory Authority)

rph pharmaceuticals ab - beclometasone dipropionate - powder for inhalation - 100 mcg microgram

Ireland - English - HPRA (Health Products Regulatory Authority)

rph pharmaceuticals ab - beclometasone dipropionate - powder for inhalation - 250 mcg microgram

Ireland - English - HPRA (Health Products Regulatory Authority)

rph pharmaceuticals ab - beclometasone dipropionate - powder for inhalation - 50 mcg microgram

Ireland - English - HPRA (Health Products Regulatory Authority)

b & s healthcare - beclometasone dipropionate - nasal spray suspension - 50 microgram

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdowell pharmaceuticals - beclometasone dipropionate - nasal spray suspension - 50 microgram

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - beclometasone dipropionate, quantity: 500 microgram/g - spray, nasal - excipient ingredients: polysorbate 80; dispersible cellulose; hydrochloric acid; glucose; purified water; benzalkonium chloride; phenethyl alcohol - for the prophylaxis or treatment of allergic rhinitis for up to 6 months in adults and children 12 years and over.

Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - beclometasone dipropionate, quantity: 100 microgram; formoterol fumarate dihydrate, quantity: 6 microgram - inhalation, pressurised - excipient ingredients: norflurane; ethanol absolute; hydrochloric acid - asthma fostair is indicated in adults (18 years and older) in the treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids (ics) and 'as needed' inhaled rapid-acting beta2-agonist or - patients already adequately controlled on both ics and long-acting beta2-agonists (laba). (see section 4.2 dose and method of administration for treatment approaches). copd (fostair 100/6 only) symptomatic treatment of adults with severe copd (fev1 less than 50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.